Akari Therapeutics, Plc (AKTX) Total liabilities 2022–2023
Akari Therapeutics, Plc (AKTX) total liabilities at each fiscal year-end, per SEC filings.
$4.6MFY2023 · since FY2022: $15.6M → $4.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $4.6M | -70.7% |
| FY2022 | $15.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice